EUCTR2019-004826-12-NL进行中（未招募）1 期
Safety and preliminary efficacy of Alkaline Phosphatase in severely burned patients - MAP4B-safety
Association of Dutch Burn Centres0 个研究点目标入组 10 人开始时间: 2021年7月22日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •partial/full thickness acute thermal burns of at least 15% TBSA
- •Admission burn ICU
- •Written informed consent from patient or legal representative
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 8
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 2
排除标准
- •Inclusion in another interventional clinical trial
- •Patients who are pregnant or lactating
- •Patients expected to have fatal disease within 24 hours
- •Patients with chemical burns
- •Patients who are having an known history of immune system that has been impaired by disease, such as patients with HIV and with a CD4 count of less than 200 cells/mm, neutropenic patients (<0.5 x 109/l) or medical treatment with immunosuppressive effects
- •Patients who have advanced chronic liver disease confirmed by a Child-Pugh C
- •Patients with active haematological malignancy
研究者
相似试验
已完成
2 期
Safety and preliminary efficacy of Alkaline Phosphatase in severely burned patientsNL-OMON52814Rode Kruis Ziekenhuis10
已完成
1 期
Safety and preliminary efficacy of Alkaline Phosphatase in severely burned patients<p>Patients with acute thermal burns of at least 15% TBSA</p>Severe burns10014982NL-OMON29043Rode Kruis Ziekenhuis10
已完成
不适用
Safety and efficacy of polyphosphate for the treatment of ulcerative colitis(AMU002-CR01)JPRN-UMIN000021555Asahikawa Medical University10
已完成
3 期
Tooth cavity disinfetion with Chitosan solution in 5-12 year old childreCTRI/2023/06/053795Dr Sreejeeta Dey96
已完成
3 期
Evaluation of the efficacy and safety of the potassium citrate tablet of immediate release vs Acalka® in urolithiasis in adults.Male Urogenital DiseasesRenal urolithiasisNephrolithiasisKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesUrolithiasisRPCEC00000333Oriente Pharmaceutical Laboratory Company